ID

35029

Descrizione

Tissue Procurement Protocol for Patients Undergoing Treatment for Early-Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02455882

collegamento

https://clinicaltrials.gov/show/NCT02455882

Keywords

versioni (1)
  1. 11/02/19 11/02/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

11 febbraio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Breast Cancer NCT02455882

Inglese

Eligibility Breast Cancer NCT02455882

1 moduli  
Criteria
Descrizione

Criteria

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
all patients must have a primary invasive breast cancer with the primary tumor intact (t2-4, any n, any m). inflammatory breast cancer is permitted.
Descrizione

Primary invasive malignant neoplasm of female breast | Primary tumor Intact TNM Breast tumor staging | Inflammatory Breast Carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4076461
UMLS CUI [2,1]
C0677930
UMLS CUI [2,2]
C0205266
UMLS CUI [2,3]
C0474926
UMLS CUI [3]
C0278601
for the neoadjuvant cohort (group 1), the patient's clinical plan includes neoadjuvant systemic therapy (chemotherapy, hormonal therapy, and/or biologic therapy) prior to surgery on the breast.
Descrizione

Neoadjuvant Therapy Systemic | Chemotherapy | Hormone Therapy | Biological treatment | Status pre- Operation on breast

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0600558
UMLS CUI [1,2]
C0205373
UMLS CUI [2]
C0392920
UMLS CUI [3]
C0279025
UMLS CUI [4]
C1531518
UMLS CUI [5,1]
C0332152
UMLS CUI [5,2]
C3714726
for the adjuvant cohort (group 2), the patient's clinical plan includes surgical resection of the primary breast mass followed by adjuvant chemotherapy (with or without endocrine therapy or biologic therapy such as trastuzumab).
Descrizione

Excision Mass in breast Primary | Chemotherapy, Adjuvant | Hormone Therapy | Hormone Therapy Absent | Biological treatment | trastuzumab

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0728940
UMLS CUI [1,2]
C0024103
UMLS CUI [1,3]
C0205225
UMLS CUI [2]
C0085533
UMLS CUI [3]
C0279025
UMLS CUI [4,1]
C0279025
UMLS CUI [4,2]
C0332197
UMLS CUI [5]
C1531518
UMLS CUI [6]
C0728747
patients in the neoadjuvant cohort must have had mammography performed at the university of michigan, or outside film review prior to enrollment.
Descrizione

Mammography

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0024671
all patients are required to sign an informed consent document regarding the experimental purpose of the research biopsies and serum banking, in accordance with the university of michigan irb standards.
Descrizione

Informed Consent | Research Biopsy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0035168
UMLS CUI [2,2]
C0005558
exclusion criteria - for the neoadjuvant cohort (group 1): tumors diagnosed by excisional biopsy, or incisional biopsy that does not leave at least 2 cm of measurable disease by physical examination, mammography, or ultrasound (with the exception of inflammatory breast cancer)
Descrizione

Exclusion Criteria | Neoplasm Excision biopsy | Incisional biopsy | Measurable Disease Absent Physical Examination | Measurable Disease Absent Mammography | Measurable Disease Absent Ultrasonography | Exception Inflammatory Breast Carcinoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C0184921
UMLS CUI [3]
C0184922
UMLS CUI [4,1]
C1513041
UMLS CUI [4,2]
C0332197
UMLS CUI [4,3]
C0031809
UMLS CUI [5,1]
C1513041
UMLS CUI [5,2]
C0332197
UMLS CUI [5,3]
C0024671
UMLS CUI [6,1]
C1513041
UMLS CUI [6,2]
C0332197
UMLS CUI [6,3]
C0041618
UMLS CUI [7,1]
C1705847
UMLS CUI [7,2]
C0278601
for the adjuvant cohort (group 2): tumors diagnosed by excisional or incisional biopsy and which are not likely to have at least 2 cm of residual tumor remaining
Descrizione

Exclusion Criteria | Neoplasms Excision biopsy | Neoplasms Incisional biopsy | Residual Tumor Size Unlikely

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C0184921
UMLS CUI [3,1]
C0027651
UMLS CUI [3,2]
C0184922
UMLS CUI [4,1]
C0543478
UMLS CUI [4,2]
C0456389
UMLS CUI [4,3]
C0750558
patients must not have received any prior chemotherapy, hormonal therapy, or radiation therapy for their current breast cancer. patients who received tamoxifen or other agents for prevention of breast cancer may be included.
Descrizione

Exclusion Criteria | Prior Chemotherapy Breast Carcinoma | Prior Hormone Therapy Breast Carcinoma | Prior radiation therapy Breast Carcinoma | Tamoxifen allowed | Preventive medication Breast Carcinoma allowed

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C1514457
UMLS CUI [2,2]
C0678222
UMLS CUI [3,1]
C1514460
UMLS CUI [3,2]
C0678222
UMLS CUI [4,1]
C0279134
UMLS CUI [4,2]
C0678222
UMLS CUI [5,1]
C0039286
UMLS CUI [5,2]
C0683607
UMLS CUI [6,1]
C1656259
UMLS CUI [6,2]
C0678222
UMLS CUI [6,3]
C0683607
patients with another active systemic malignancy within the past year.
Descrizione

Exclusion Criteria | Cancer Other Systemic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C1707251
UMLS CUI [2,2]
C0205373
entry criteria for patients with newly diagnosed locoregional or distant disease recurrence (who did not enroll at the time of initial adjuvant or neoadjuvant chemotherapy) (group 3)
Descrizione

Locoregional Neoplasm Recurrence | Distant metastasis Recurrent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0027643
UMLS CUI [2,1]
C1269798
UMLS CUI [2,2]
C2945760
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must have been previously diagnosed with non-invasive or invasive breast cancer.
Descrizione

Prior diagnosis Breast Carcinoma | Prior diagnosis Invasive carcinoma of breast

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332132
UMLS CUI [1,2]
C0678222
UMLS CUI [2,1]
C0332132
UMLS CUI [2,2]
C0853879
patients must have been diagnosed with biopsy-proven recurrence of breast cancer at any site
Descrizione

Breast cancer recurrent Biopsy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C0005558
all patients are required to sign an informed consent document regarding the experimental purpose of the research biopsies and serum banking, in accordance with the university of michigan irb standards.
Descrizione

Informed Consent | Research Biopsy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0035168
UMLS CUI [2,2]
C0005558
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients must not have received any chemotherapy, hormonal therapy, or radiation therapy for treatment of their recurrent breast cancer.
Descrizione

Chemotherapy Breast cancer recurrent | Hormone Therapy Breast cancer recurrent | Therapeutic radiology procedure Breast cancer recurrent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0278493
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C0278493
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0278493
patients must not have been diagnosed with another active systemic malignancy within the past year.
Descrizione

Cancer Other Systemic

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1707251
UMLS CUI [1,2]
C0205373
Ritorna all'inizio della pagina

Similar models

Eligibility Breast Cancer NCT02455882

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Primary invasive malignant neoplasm of female breast | Primary tumor Intact TNM Breast tumor staging | Inflammatory Breast Carcinoma
Item
all patients must have a primary invasive breast cancer with the primary tumor intact (t2-4, any n, any m). inflammatory breast cancer is permitted.
boolean
C4076461 (UMLS CUI [1])
C0677930 (UMLS CUI [2,1])
C0205266 (UMLS CUI [2,2])
C0474926 (UMLS CUI [2,3])
C0278601 (UMLS CUI [3])
Neoadjuvant Therapy Systemic | Chemotherapy | Hormone Therapy | Biological treatment | Status pre- Operation on breast
Item
for the neoadjuvant cohort (group 1), the patient's clinical plan includes neoadjuvant systemic therapy (chemotherapy, hormonal therapy, and/or biologic therapy) prior to surgery on the breast.
boolean
C0600558 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C1531518 (UMLS CUI [4])
C0332152 (UMLS CUI [5,1])
C3714726 (UMLS CUI [5,2])
Excision Mass in breast Primary | Chemotherapy, Adjuvant | Hormone Therapy | Hormone Therapy Absent | Biological treatment | trastuzumab
Item
for the adjuvant cohort (group 2), the patient's clinical plan includes surgical resection of the primary breast mass followed by adjuvant chemotherapy (with or without endocrine therapy or biologic therapy such as trastuzumab).
boolean
C0728940 (UMLS CUI [1,1])
C0024103 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,3])
C0085533 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C0279025 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C1531518 (UMLS CUI [5])
C0728747 (UMLS CUI [6])
Mammography
Item
patients in the neoadjuvant cohort must have had mammography performed at the university of michigan, or outside film review prior to enrollment.
boolean
C0024671 (UMLS CUI [1])
Informed Consent | Research Biopsy
Item
all patients are required to sign an informed consent document regarding the experimental purpose of the research biopsies and serum banking, in accordance with the university of michigan irb standards.
boolean
C0021430 (UMLS CUI [1])
C0035168 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
Exclusion Criteria | Neoplasm Excision biopsy | Incisional biopsy | Measurable Disease Absent Physical Examination | Measurable Disease Absent Mammography | Measurable Disease Absent Ultrasonography | Exception Inflammatory Breast Carcinoma
Item
exclusion criteria - for the neoadjuvant cohort (group 1): tumors diagnosed by excisional biopsy, or incisional biopsy that does not leave at least 2 cm of measurable disease by physical examination, mammography, or ultrasound (with the exception of inflammatory breast cancer)
boolean
C0680251 (UMLS CUI [1])
C0027651 (UMLS CUI [2,1])
C0184921 (UMLS CUI [2,2])
C0184922 (UMLS CUI [3])
C1513041 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0031809 (UMLS CUI [4,3])
C1513041 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0024671 (UMLS CUI [5,3])
C1513041 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C0041618 (UMLS CUI [6,3])
C1705847 (UMLS CUI [7,1])
C0278601 (UMLS CUI [7,2])
Exclusion Criteria | Neoplasms Excision biopsy | Neoplasms Incisional biopsy | Residual Tumor Size Unlikely
Item
for the adjuvant cohort (group 2): tumors diagnosed by excisional or incisional biopsy and which are not likely to have at least 2 cm of residual tumor remaining
boolean
C0680251 (UMLS CUI [1])
C0027651 (UMLS CUI [2,1])
C0184921 (UMLS CUI [2,2])
C0027651 (UMLS CUI [3,1])
C0184922 (UMLS CUI [3,2])
C0543478 (UMLS CUI [4,1])
C0456389 (UMLS CUI [4,2])
C0750558 (UMLS CUI [4,3])
Exclusion Criteria | Prior Chemotherapy Breast Carcinoma | Prior Hormone Therapy Breast Carcinoma | Prior radiation therapy Breast Carcinoma | Tamoxifen allowed | Preventive medication Breast Carcinoma allowed
Item
patients must not have received any prior chemotherapy, hormonal therapy, or radiation therapy for their current breast cancer. patients who received tamoxifen or other agents for prevention of breast cancer may be included.
boolean
C0680251 (UMLS CUI [1])
C1514457 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1514460 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
C0279134 (UMLS CUI [4,1])
C0678222 (UMLS CUI [4,2])
C0039286 (UMLS CUI [5,1])
C0683607 (UMLS CUI [5,2])
C1656259 (UMLS CUI [6,1])
C0678222 (UMLS CUI [6,2])
C0683607 (UMLS CUI [6,3])
Exclusion Criteria | Cancer Other Systemic
Item
patients with another active systemic malignancy within the past year.
boolean
C0680251 (UMLS CUI [1])
C1707251 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
Locoregional Neoplasm Recurrence | Distant metastasis Recurrent
Item
entry criteria for patients with newly diagnosed locoregional or distant disease recurrence (who did not enroll at the time of initial adjuvant or neoadjuvant chemotherapy) (group 3)
boolean
C0027643 (UMLS CUI [1])
C1269798 (UMLS CUI [2,1])
C2945760 (UMLS CUI [2,2])
Item Group
C1512693 (UMLS CUI)
Prior diagnosis Breast Carcinoma | Prior diagnosis Invasive carcinoma of breast
Item
patients must have been previously diagnosed with non-invasive or invasive breast cancer.
boolean
C0332132 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0332132 (UMLS CUI [2,1])
C0853879 (UMLS CUI [2,2])
Breast cancer recurrent Biopsy
Item
patients must have been diagnosed with biopsy-proven recurrence of breast cancer at any site
boolean
C0278493 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Informed Consent | Research Biopsy
Item
all patients are required to sign an informed consent document regarding the experimental purpose of the research biopsies and serum banking, in accordance with the university of michigan irb standards.
boolean
C0021430 (UMLS CUI [1])
C0035168 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Breast cancer recurrent | Hormone Therapy Breast cancer recurrent | Therapeutic radiology procedure Breast cancer recurrent
Item
patients must not have received any chemotherapy, hormonal therapy, or radiation therapy for treatment of their recurrent breast cancer.
boolean
C0392920 (UMLS CUI [1,1])
C0278493 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2,1])
C0278493 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0278493 (UMLS CUI [3,2])
Cancer Other Systemic
Item
patients must not have been diagnosed with another active systemic malignancy within the past year.
boolean
C1707251 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial